We are live on ! Find out more
VDI

Vaughan David Investments Portfolio holdings

AUM $4.73B
1-Year Est. Return 19.55%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+19.55%
3 Year Est. Return
+59.13%
5 Year Est. Return
+79.37%
10 Year Est. Return
+243.14%
AUM
$4.6B
AUM Growth
-$38.5M
Cap. Flow
-$21.5M
Cap. Flow %
-0.47%
Top 10 Hldgs %
20.7%
Holding
235
New
8
Increased
71
Reduced
96
Closed
10

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33.5M
2
CNP icon
CenterPoint Energy
CNP
+$27.7M
3
PGR icon
Progressive
PGR
+$25.1M
4
BSCV icon
Invesco BulletShares 2031 Corporate Bond ETF
BSCV
+$4.61M
5
SOLS
Solstice Advanced Materials
SOLS
+$2.75M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$35.5M
2
D icon
Dominion Energy
D
+$23.6M
3
AVGO icon
Broadcom
AVGO
+$13.2M
4
ORCL icon
Oracle
ORCL
+$12.9M
5
LRCX icon
Lam Research
LRCX
+$5.37M

Sector Composition

Rank Sector Weight
1 Financials 19.4%
2 Technology 15.1%
3 Utilities 13.83%
4 Healthcare 12.56%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XEL icon
26
Xcel Energy
XEL
$48.8B
$52.5M 1.14%
710,689
+38
+0% +$3K
ABT icon
27
Abbott
ABT
$187B
$52.3M 1.14%
417,344
+175
+0% +$22.3K
WEC icon
28
WEC Energy
WEC
$35.1B
$51.3M 1.12%
486,888
-3,159
-0.6% -$350K
SO icon
29
Southern Company
SO
$107B
$51.1M 1.11%
585,521
+3,045
+0.5% +$278K
T icon
30
AT&T
T
$163B
$50.9M 1.11%
2,047,942
+15,021
+0.7% +$380K
CEG icon
31
Constellation Energy
CEG
$96.4B
$50.8M 1.1%
143,714
-8,837
-6% -$3.21M
RGA icon
32
Reinsurance Group of America
RGA
$16.1B
$50.1M 1.09%
246,330
-1,866
-0.8% -$361K
PM icon
33
Philip Morris
PM
$295B
$50.1M 1.09%
312,254
-3,899
-1% -$604K
LNT icon
34
Alliant Energy
LNT
$18B
$50.1M 1.09%
769,972
+1,263
+0.2% +$84.6K
CVX icon
35
Chevron
CVX
$366B
$49.8M 1.08%
326,628
+2,353
+0.7% +$358K
UNH icon
36
UnitedHealth
UNH
$370B
$49.8M 1.08%
150,773
+3,934
+3% +$1.33M
RMD icon
37
ResMed
RMD
$30.7B
$49.4M 1.07%
204,931
+794
+0.4% +$203K
DUK icon
38
Duke Energy
DUK
$97.3B
$49.4M 1.07%
421,070
+745
+0.2% +$91K
COP icon
39
ConocoPhillips
COP
$141B
$48.9M 1.06%
522,858
-661
-0.1% -$59.8K
XOM icon
40
ExxonMobil
XOM
$634B
$48.1M 1.05%
399,862
-3,261
-0.8% -$378K
HON icon
41
Honeywell
HON
$78B
$47.5M 1.03%
243,682
-12,194
-5% -$2.39M
MRSH
42
Marsh
MRSH
$91.5B
$46.9M 1.02%
252,873
-1,090
-0.4% -$204K
AZN icon
43
AstraZeneca
AZN
$250B
$46.3M 1.01%
251,759
-3,231
-1% -$567K
ICE icon
44
Intercontinental Exchange
ICE
$84.4B
$46M 1%
284,281
+1,635
+0.6% +$256K
DTE icon
45
DTE Energy
DTE
$29.1B
$45.7M 0.99%
353,957
+1,576
+0.4% +$214K
USB icon
46
US Bancorp
USB
$99.6B
$44.9M 0.98%
840,863
+2,206
+0.3% +$109K
LMT icon
47
Lockheed Martin
LMT
$136B
$44.7M 0.97%
92,422
+416
+0.5% +$199K
KO icon
48
Coca-Cola
KO
$375B
$44.5M 0.97%
636,632
+361
+0.1% +$25.2K
PG icon
49
Procter & Gamble
PG
$339B
$43.8M 0.95%
305,383
+2,230
+0.7% +$329K
MRK icon
50
Merck
MRK
$318B
$43.6M 0.95%
413,995
+1,754
+0.4% +$165K
1
2
3 4 5

Similar funds

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Vaughan David Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Vaughan David Investments held 235 positions worth $4.6B, down 0.83% from $4.64B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Vaughan David Investments's Q4 2025 filing shows 8 new, 71 increased, 96 reduced and 10 closed positions. Its largest new stake was Gilead Sciences: 275,391 shares worth $33.8M. The largest sale was Amgen, an estimated $35.5M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Utilities.

  • Vaughan David Investments's largest Q4 2025 buy was Gilead Sciences: 275,391 shares worth $33.8M.
  • Vaughan David Investments added most to Progressive in Q4 2025, an estimated $25.1M increase.
  • Vaughan David Investments's biggest Q4 2025 reduction was Amgen, cutting an estimated $35.5M.
  • Vaughan David Investments fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $4.12M.
  • Vaughan David Investments's ten largest holdings make up 21% of its $4.6B portfolio in Q4 2025.
  • Vaughan David Investments opened 8 new positions and closed 10 in Q4 2025.
  • Vaughan David Investments's portfolio value fell 0.83% quarter-over-quarter to $4.6B.

Based on Vaughan David Investments's 13F filing for Q4 2025, filed 12 Feb 2026.